Table 6.
Summary of the results of some studies regarding the utility of fecal calprotectin in prediction of relapse in IBD patients.
| Number of patients | Age group | Study location | Cut off | Sensitivity | Specificity | Reference |
|---|---|---|---|---|---|---|
| 62 (CD and UC) | Pediatric | Netherlands | 500 (μg/g) | 67% | 81% | [108], |
| 79 (CD and UC) | Adults | Italy | 150 (μg/g) | 89%(UC) 87%(CD) |
82%(UC) 43%(CD) |
[92], |
| 163 (CD and UC) | Adults | Spain | 150 (μg/g) | 69% | 69% | [96], |
| 73 (CD and UC) | Pediatric | Italy | 275 (μg/g) | 97% | 85% | [109], |
| 53 (CD) | Adults | Tunisia | 340 (μg/g) | 80% | 90.7% | [95], |
| 64 (UC) | Adults | Spain | 250 (μg/g) | 41% | 85% | [93], |
| 80 (UC) | Adults | Japan | 170 (μg/g) | 76% | 76% | [110], |
| 157 (UC) | Adults | Iran | 341 (μg/g) | 80% | 89% | [111], |
| 62 (CD) | Adults | China | 225 (μg/g) | 69% | 78.8% | [112], |
| 65 (CD) | Adults | France | 130(μg/g) | 61% | 48% | [94], |
| 53 (CD and UC) | Adults | Spain | 160 (μg/g) | 91.7% | 81.9% | [97], |
| 95 (CD and UC) | Adults | Spain | 130 (μg/g) | 100% | 80% | [98], |
| 72 (CD and UC) | Pediatric | Finland | 82 (μg/g) | 38% | 80% | [113], |
| 162 (CD and UC) | Adults | Italy | 130 (μg/g) | 68% | 67% | [114], |